Review decision date: March 2015
The next surveillance review of the guideline should be scheduled at the same time as the 2 year review of the medicines optimisation (NG5), due to the overlap between the two guidelines.
Next review date: March 2017
This guidance is about enabling patients to make informed choices by involving and supporting them in decisions about prescribed medicines. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence) to the NHS in England and Wales.
Responsibility for undertaking a review of this guidance at the designated review date has passed to the National Clinical Guidelines Centre for Acute and Chronic Conditions (NCGCACC). The National Collaborating Centre for Primary Care is no longer active.
Recommendation 1.4.2 has been replaced by recommendations in the NICE guideline on medicines optimisation.